Telehealth available in Idaho, Utah, and Oregon. Covered by most major insurances.
Opioid drugs such as morphine and oxycodone are very effective for treating pain, but they can lead to overdose and addiction after long-term use. But millions of people out there are struggling with one chronic pain or the other, and they need a way to manage the pain daily without worrying about getting addicted. If you’re like one of them asking what pain medication is best for chronic pain, you’re in luck!
Researchers have discovered a non-opioid non-addictive pain medicine with fewer side effects than existing painkillers. This new compound, BnOCPA, is considered the best and safest pain medication because it acts selectively on G protein, thereby reducing its potential side effects.
Most painkillers work by activating molecules known as G proteins. The activation of G proteins can lead to many cellular side effects like stomach bleeding, kidney problems, and liver damage. BnOCPA is unique as it only activates one type of G protein, thereby reducing the potential side effects. This non-addictive pain medicine is therefore safer for long-term use as it does not expose you to those worrisome risks.
But of course, there are medications you can take alongside opioid meds to inhibit the addictive effects. But why take two pills when you could use one?
Chronic pain can impair one’s quality of life and prevent them from doing all the activities they once enjoyed. Sadly, if you’re currently using prescription pain medicine, you might be at risk of far worse. About 29% of people using opioid prescription end up abusing them, and over 33,000 Americans died of opioid overdose in 2015. That’s a cause for concern.
If you worry about the risk of getting addicted or are already facing addiction, there’s hope. The new non-addictive pain medicine (BnOCPA) recently discovered opens up opportunities for the development of new, safer analgesics.
“The more we looked into BnOCPA, we discovered properties that had never been seen before, and which may open up new areas of medicinal chemistry,” said Professor Bruno Frenguelli.